Walleye Trading LLC Editas Medicine, Inc. Put Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Put Options

23 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$6.25 - $11.11 $625 - $1,111	100 New	100 $1,000
Q2 2023 Aug 14, 2023	SELL	$6.36 - $11.47 $382,872 - $690,494	-60,200 Reduced 91.21%	5,800 $47,000
Q1 2023 May 15, 2023	SELL	$7.03 - $11.53 $142,709 - $234,059	-20,300 Reduced 23.52%	66,000 $478,000
Q4 2022 Feb 14, 2023	BUY	$8.32 - $13.21 $153,920 - $244,385	18,500 Added 27.29%	86,300 $765,000
Q3 2022 Nov 14, 2022	SELL	$12.16 - $19.42 $89,984 - $143,708	-7,400 Reduced 9.84%	67,800 $830,000
Q2 2022 Aug 08, 2022	SELL	$9.99 - $21.35 $596,403 - $1.27 Million	-59,700 Reduced 44.26%	75,200 $890,000
Q1 2022 May 16, 2022	BUY	$14.08 - $27.63 $894,080 - $1.75 Million	63,500 Added 88.94%	134,900 $2.57 Million
Q4 2021 Feb 14, 2022	BUY	$26.55 - $40.57 $939,870 - $1.44 Million	35,400 Added 98.33%	71,400 $1.9 Million
Q3 2021 Nov 15, 2021	BUY	$39.27 - $72.94 $1.31 Million - $2.43 Million	33,300 Added 1233.33%	36,000 $1.48 Million
Q2 2021 Aug 16, 2021	BUY	$31.29 - $56.64 $12,516 - $22,656	400 Added 17.39%	2,700 $153,000
Q1 2021 May 17, 2021	BUY	$39.71 - $90.58 $47,652 - $108,696	1,200 Added 109.09%	2,300 $97,000
Q4 2020 Feb 16, 2021	SELL	$27.07 - $84.35 $132,643 - $413,315	-4,900 Reduced 81.67%	1,100 $77,000
Q3 2020 Nov 16, 2020	BUY	$28.06 - $37.16 $165,554 - $219,243	5,900 Added 5900.0%	6,000 $168,000
Q2 2020 Aug 14, 2020	SELL	$18.5 - $34.34 $131,350 - $243,814	-7,100 Reduced 98.61%	100 $3,000
Q1 2020 May 15, 2020	SELL	$14.88 - $32.78 $47,616 - $104,896	-3,200 Reduced 30.77%	7,200 $143,000
Q4 2019 Feb 14, 2020	SELL	$19.49 - $32.63 $37,031 - $61,997	-1,900 Reduced 15.45%	10,400 $308,000
Q3 2019 Nov 14, 2019	BUY	$22.49 - $26.81 $8,996 - $10,724	400 Added 3.36%	12,300 $280,000
Q2 2019 Aug 14, 2019	BUY	$20.48 - $27.76 $96,256 - $130,472	4,700 Added 65.28%	11,900 $294,000
Q1 2019 May 15, 2019	SELL	$19.43 - $26.41 $868,521 - $1.18 Million	-44,700 Reduced 86.13%	7,200 $176,000
Q4 2018 Feb 14, 2019	BUY	$18.19 - $31.79 $522,053 - $912,373	28,700 Added 123.71%	51,900 $1.18 Million
Q3 2018 Nov 14, 2018	SELL	$27.65 - $38.39 $132,720 - $184,272	-4,800 Reduced 17.14%	23,200 $738,000
Q2 2018 Aug 14, 2018	SELL	$31.4 - $41.01 $141,300 - $184,545	-4,500 Reduced 13.85%	28,000 $1 Million
Q1 2018 May 15, 2018	BUY	$29.84 - $44.08 $969,800 - $1.43 Million	32,500 New	32,500 $1.08 Million

Others Institutions Holding EDIT

# of Institutions

244

Shares Held

56.8M

Call Options Held

410K

Put Options Held

394K

Black Rock Inc. New York, NY

7.78M
Shares

$10.2 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

6.68M
Shares

$8.75 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

4.9M
Shares

$6.42 Million
0.62% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.35M
Shares

$4.39 Million
0.01% of portfolio
State Street Corp Boston, MA

2.46M
Shares

$3.23 Million
0.0% of portfolio

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account